Kuhn Tsai is a Medical Device Analyst. Prior to joining OrbiMed, he worked at Eos Partners as a Healthcare Analyst/Junior Portfolio Manager. He previously researched the healthcare sector with the Galleon Group and Goldman Sachs. Dr. Tsai received his M.D. and M.B.A. degrees from the University of Chicago and his B.A. from Harvard University.